The supply chain for artemisinin, the key drug in Artemisinin Combination Therapies, is complex and challenging
30% of needed supply of artemisinin is produced semi-synthetically by Sanofi, while the remainder must come from A. annua plant extraction
Will the crop supply enough material for global demand?
Zagaya is working to ensure affordable access of these life-saving drugs for all in need
The journey to semi-synthetic artemisinin
Explore the World Malaria Day 2013 Symposium
Zagaya just hosted the second annual Bay Area World Malaria Day Symposium on April 25th. Click here for highlights, photos and more about the event!
Human life has value, and no one wants others to die unnecessarily. Malaria has been eliminated in so much of our globe already (maps courtesy UCSF Global Health group), that we know global elimination is close. Make a difference in the fight against malaria; collaborate, partner and share our knowledge for a malaria-free world! Learn more